Healthpeak Properties (NYSE:DOC – Get Free Report) had its target price dropped by research analysts at Robert W. Baird from $20.00 to $19.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the real estate investment trust’s stock. Robert W. Baird’s target price would indicate a potential upside of 12.59% from the company’s current price.
Several other brokerages also recently weighed in on DOC. Weiss Ratings upgraded Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 26th. Jefferies Financial Group downgraded Healthpeak Properties from a “buy” rating to a “hold” rating and lowered their target price for the company from $21.00 to $17.00 in a research note on Monday, December 15th. The Goldman Sachs Group began coverage on Healthpeak Properties in a research note on Friday, January 9th. They set a “neutral” rating and a $17.00 target price for the company. Cantor Fitzgerald set a $17.00 target price on Healthpeak Properties in a research note on Monday, January 5th. Finally, Evercore lowered their target price on Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating for the company in a research note on Wednesday, February 4th. Six research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $19.19.
Read Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Stock Up 1.2%
Healthpeak Properties (NYSE:DOC – Get Free Report) last announced its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.02. The company had revenue of $719.40 million during the quarter, compared to the consensus estimate of $685.14 million. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The company’s revenue was up 3.1% on a year-over-year basis. During the same period last year, the firm earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Research analysts anticipate that Healthpeak Properties will post 1.86 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of large investors have recently bought and sold shares of DOC. Integrated Wealth Concepts LLC lifted its holdings in Healthpeak Properties by 7.3% during the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock worth $366,000 after buying an additional 1,231 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Healthpeak Properties by 110.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock worth $2,463,000 after buying an additional 63,930 shares during the last quarter. Woodline Partners LP lifted its holdings in Healthpeak Properties by 41.3% during the 1st quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock worth $1,195,000 after buying an additional 17,279 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in Healthpeak Properties by 12.7% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 48,441 shares of the real estate investment trust’s stock worth $848,000 after buying an additional 5,445 shares during the last quarter. Finally, Panagora Asset Management Inc. bought a new position in Healthpeak Properties during the 2nd quarter worth approximately $235,000. Institutional investors own 93.57% of the company’s stock.
About Healthpeak Properties
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Read More
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
